UBC’s participation in a smallpox vaccine study was recently cited in the journal, Vaccine. The prospective study involved the enrollment of 20,136 subjects who were active-duty military personnel undergoing pre-deployment medical readiness. The trial was initiated to address safety concerns related to myopericarditis.
UBC, a leader in global late-stage and patient support services for the biopharmaceutical industry, introduces UBC Pathways® Engage – a digital concierge that transforms traditional patient education, support and communications through a combination of proprietary engagement methodologies and mobile messaging technology. UBC Pathways® Engage is purpose-built to help patients start and stay on therapy.
UBC, a global leader of late-stage and patient support services, has broadened its electronic benefits verification system, which provides real-time benefit checks to the broadest reach of covered lives in the United States.
UBC, a global leading provider of late-stage and patient support services, held a ribbon-cutting ceremony for the grand opening of a 43,000 square foot facility located at 680 Century Point, Lake Mary, FL due to expansion of the business.